Astellas Announces Data from ASPIRO Study in X-linked Myotubular Myopathy Published in The Lancet Neurology

Preliminary data analysis on ventilator dependence and motor improvement are reported alongside overall safety findings
TOKYO, Nov. 15, 2023 /PRNewswire/ -- Astellas Pharma Inc. today announced...

Related Keywords

University Of California Los Angeles ,California ,United States ,South San Francisco ,Tsukuba ,Ibaraki ,Japan ,San Francisco ,Tokyo ,Richard Wilson ,Perryb Shieh ,Naoki Okamura ,Prnewswire Astellas Pharma Inc ,Drug Administration ,European Medicines Agency ,Astellas Pharma Inc ,Astellas Center ,Lancet Neurology ,California Los Angeles ,Principal Investigator ,Senior Vice President ,Primary Focus Lead ,Genetic Regulation ,Regenerative Medicine ,Advanced Therapy ,Rare Pediatric Disease ,Fast Track ,Orphan Drug ,Priority Medicines ,Focus Area Approach ,Gene Therapies ,Markets ,